Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer

BMC Genomics. 2015 Mar 27;16(1):247. doi: 10.1186/s12864-015-1446-z.

Abstract

Background: Chimeric read-through RNAs are transcripts originating from two directly adjacent genes (<10 kb) on the same DNA strand. Although they are found in next-generation whole transcriptome sequencing (RNA-Seq) data on a regular basis, investigating them further has usually been refrained from. Therefore, their expression patterns or functions in general, and in oncogenesis in particular, are poorly understood.

Results: We used paired-end RNA-Seq and a specifically designed computational data analysis pipeline (FusionSeq) to nominate read-through events in a small discovery set of renal cell carcinomas (RCC) and confirmed them in a larger validation cohort. 324 read-through events were called overall; 22/27 (81%) selected nominees passed validation with conventional PCR and were sequenced at the junction region. We frequently identified various isoforms of a given read-through event. 2/22 read-throughs were up-regulated: BC039389-GATM was higher expressed in RCC compared to benign adjacent kidney; KLK4-KRSP1 was expressed in 46/169 (27%) RCCs, but rarely in normal tissue. KLK4-KRSP1 expression was associated with worse clinical outcome in the patient cohort. In cell lines, both read-throughs influenced molecular mechanisms (i.e. target gene expression or migration/invasion) in a way that counteracted the effect of the respective parent transcript GATM or KLK4.

Conclusions: Our data suggests that the up-regulation of read-through RNA chimeras in tumors is not random but causes regulatory effects on cellular mechanisms and may impact patient survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amidinotransferases / antagonists & inhibitors
  • Amidinotransferases / genetics*
  • Amidinotransferases / metabolism
  • Base Sequence
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / pathology
  • Cell Line
  • Cohort Studies
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Kallikreins / antagonists & inhibitors
  • Kallikreins / genetics*
  • Kallikreins / metabolism
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Oncogene Proteins, Fusion / antagonists & inhibitors
  • Oncogene Proteins, Fusion / genetics*
  • Oncogene Proteins, Fusion / metabolism
  • RNA Interference
  • RNA, Messenger / chemistry
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / metabolism
  • Sequence Analysis, RNA
  • Survival Analysis
  • Up-Regulation

Substances

  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • RNA, Small Interfering
  • Amidinotransferases
  • glycine amidinotransferase
  • Kallikreins
  • kallikrein 4

Associated data

  • GENBANK/KM576708
  • GENBANK/KM576709
  • GENBANK/KM576710
  • GENBANK/KM576711
  • GENBANK/KM576712
  • GENBANK/KM576713
  • GENBANK/KM576714
  • GENBANK/KM576715
  • GENBANK/KM576716
  • GENBANK/KM576717
  • GENBANK/KM576718
  • GENBANK/KM576719
  • GENBANK/KM576720
  • GENBANK/KM576721
  • GENBANK/KM576722
  • GENBANK/KM576723
  • GENBANK/KM576724
  • GENBANK/KM576725
  • GENBANK/KM576726
  • GENBANK/KM576727
  • GENBANK/KM576728
  • GENBANK/KM576729
  • GENBANK/KM576730
  • GENBANK/KM576731
  • GENBANK/KM576732
  • GENBANK/KM576733
  • GENBANK/KM576734
  • GENBANK/KM576735
  • GENBANK/KM576736
  • GENBANK/KM576737
  • GENBANK/KM576738
  • GENBANK/KM576739
  • GENBANK/KM576740
  • GENBANK/KM576741
  • GENBANK/KM576742
  • GENBANK/KM576743
  • GENBANK/KM576744
  • GENBANK/KM576745
  • GENBANK/KM576746
  • GENBANK/KM576747
  • GENBANK/KM576748
  • GENBANK/KM576749
  • GENBANK/KM576750
  • GENBANK/KM576751
  • GENBANK/KM576752
  • GENBANK/KM576753
  • GENBANK/KM576754
  • GENBANK/KM576755
  • GENBANK/KM576756
  • GENBANK/KM576757